Foundation Medicine ($FMI) is rolling out a cancer genomics software system for next-generation sequencing (NGS) tests, building out its offerings amid an ...
New next generation sequencing (NGS) technologies that can examine millions of DNA variants at a time and help inform treatment decisions are at the heart of two new draft guidance documents released ...